CASP9 and malignant colon neoplasm: One study found that inhibition of casp-9 can induce PD-L1 upregulation in colon cancer cells, demonstrating the potential efficacy of ICIs in conjunction with pyroptosis-inducing drugs (Han et al., 2020).